Extracorporeal Organ Support and Anticoagulation With Antiplatelet Medication*

Warwick Butt
DOI: https://doi.org/10.1097/pcc.0000000000003393
2024-01-04
Pediatric Critical Care Medicine
Abstract:Over the last 40 years, extracorporeal organ support therapy (ECOST) has become a routine therapy for many critically ill children, cared for in a PICU. The types of modalities used include renal replacement therapy (RRT), hemadsorption, molecular adsorbent recirculating system (MARS), total plasma exchange (TPE), extracorporeal membrane oxygenation (ECMO), and mechanical circulatory support (MCS). All of these technologies have similar issues associated with their use in clinical medicine, namely: 1) vascular access, 2) equipment failure, 3) infection, 4) thromboembolism, and 5) hemorrhage. Anticoagulation of these circuits is essential to maintain their functionality, but as ECOST has been increasingly applied to children with more complex clinical diseases, such as septic shock, liver failure, etc (and these patients will have very complex hematological problems with both increased risks of thrombosis and increased risks of bleeding), the management of circuit anticoagulation has had to be modified to deal safely with these situations. The choices include: 1) systemic heparin (targeted to an activated clotting time [ACT], activated partial thromboplastin time [APTT], or anti-Xa); 2) regional citrate anticoagulation (targeted to an ionized calcium); 3) bivalirudin (targeted to an APTT); or 4) antiplatelet drugs (which may be monitored by modern thromboelastography). Decisions about which type of anticoagulation should or could be used require consideration about patient factors (primary disease and relevant comorbidities, severity of illness and most importantly coagulation status of the patient, both thrombotic and bleeding risks) and effectiveness and complications of the various anticoagulants (as well as the ability to monitor and target medication to a safe therapeutic level). However, before we consider these issues, let us remind ourselves of the blood-foreign surface interaction.
pediatrics,critical care medicine
What problem does this paper attempt to address?